Supercharging Drug Discovery

We are a pharmaceutical development company equipped with our own AI Bio Supercomputing Center, pioneering the development of the core technology behind the AI drug development platform, DeepMatcher®. Additionally, we are actively engaged in establishing the STB CLOUD infrastructure and uncovering an inventory of factory-level drug candidate stocks, known as the LaunchPad. Our competitive edge lies in the fusion of IT, BT and DT to realize High-Throughput (HT) with the aim of practicing the convergence of IT, BT and DT.